New aspects of the mechanisms of development and treatment of irritable bowel syndrome

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract


In 121 children with irritable bowel syndrome (IBS) a complex evaluation of the values of volum threshold sensitivity (VTS) of the rectum, intestinal microbiota according to the findings of feces analysis and lactulose hydrogen test, and also of the activation of inflammation according to endoscopy, histology, stool calprotectin testing and proinflammatory cytokines in the colonic mucosa was performed. The estimation of these parameters before and after treatment with probiotics, trimebutin, combination therapy of pro-and prebiotics, combination therapy trimebutin and probiotics for 1 month. The control group were children receiving placebo. In all patients with IBS enhanced VTS was noted. Signs of inflammation were detected according to the findings of endoscopy in 66.9 %, of histology – in 97.5 %, enhanced levels of calprotectin were found in 27.3 %, enhanced levels of IL-8 — 45 at %, INF-γ — 90 %. In all patients with IBS have disbiotic disorders of the colon, sings of bacterial overgrowth syndrome were detected in 85.1 % of children. Probiotics effective in reducing the VTS, improving of clinical data,microbiological indices, and coping with of inflammatory disorders in the intestines. Are the most effective of treatment with both trimebutin and probiotics, or probiotics and prebiotic lasting at least one month.

Full Text

Restricted Access

About the authors

Mariya Yuryevna Tipikina

Saint-Petersburg State Pediatric Medical University

Email: romanmary@yandex.ru
Postgraduate Student, Assistant Professor, Department of Gastroenterology

Yelena Aleksandrovna Korniyenko

Saint-Petersburg State Pediatric Medical University

Email: elenkornienko@yandex.ru
PhD, Dr Med Sci, Professor, Head, Department of Gastroenterology

References

  1. Баранская Е. К. Синдром раздраженного кишечника: диагностика и лечение // Consilium medicum. — 2000. — Т. 2, № 7.
  2. Баранская Е. К. Синдром раздраженного кишечника: диагностика и лечение // Consilium medicum. — 2002. — Т. 4, № 9.
  3. Дзяк Г. В., Залєвський В. І., Степанов Ю. М. Функційні захворювання кишечника. — Днепропетровск: ПП «Ліра ЛТД», 2004. — 200 с.
  4. Дорофеев А. Э., О. А. Рассохина О. А. Синдром раздраженного кишечника — современный взгляд на проблему // Газета «Новости медицины и фармации» Гастроэнтерология (358) 2011 (тематический номер).
  5. Жуков Н. А. и соавт. Современные представления о патогенезе синдрома раздраженного кишечника //Клиническая медицина. — 2003. — № 12. — С. 7–12.
  6. Костенко М. Б., Ливзан М. А. Механизмы развития синдрома раздраженного кишечника // Сибирский журнал гастроэнтерологии и гепатологии. — 2000. — № 10. — С. 32–35.
  7. Маев И. В., Черемушкин С. В. Синдром раздраженного кишечника. Римские критерии І // Consilium Medicum. Гастроэнтерология. — 2007. — Т. 1. — С. 29–34.
  8. Хавкин А. И., Бельмер С. В., Волынец Г. В., Жихарева Н. С. Функциональные заболевания пищеварительного тракта у детей. Принципы рациональной терапии // Справочник педиатра: ежемесячный научно-практич. журнал. — 2006. — № 2. — С. 17–32.
  9. Andrews E. B., Eaton S. C., Hollis K.A. et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey // Aliment Pharmacol. Ther. — 2005. — Vol. 22. — P. 935–942.
  10. Chang L. Epidemiology and quality of life in functional gastrointestinal disorders [review article]. Aliment Pharmacol. Ther. — 2004. — Vol. 20 (suppl. 7). — P. 31–39.
  11. Collins S. М. The immunomodulation of enteric neuromuscular function: Implications for motility and inflamatory disorders // Gastroenterology. — 1996. — N 11. — Р. 1683–1699.
  12. Gerson M. D. Importance of serotonergic mechanisms in gastrointestinal motility and sensation // Irritable bowel syndrome. Diagnosis and treatment / ed. by M. Camilleri, R. C. Spiller. — London: W. B. Sounders. — 2002. — P. 240–248.
  13. Kim H. J., Camilleri M., Carlson P. J. et al. Association of distinct alpha (2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders //Gut. — 2004. — Vol. 53. — P. 829–837.
  14. Lembo A. J., Drossman D. A. Contemporaty diagnosis and management of irritable bowel syndrome. — 2002. — P. 148.
  15. Locke G. R., Zinsmeister A., Talley N. J., Fett S. L., Melton J. Familial association in adults with functional gastrointestinal disorders // Mayo Clin Proc. — 2000. — Vol. 75. — P. 907–912.
  16. Longstreth G. F., Drossman D. A. Severe irritable bowel and functional abdominal pain syndromes: managing the patient and health care costs // Clin. Gastroenterol. Hepatol. — 2005. — Vol. 3. — P. 397–400.
  17. Otte J. M., Podolsky D. K. Functional modulation on enterocytes by Gram-positive and Gram-negative microorganisms // Am. J. Physiol. Gastrointest. Liver Physiol. — 2004. — Vol. 286. — P. 613–626.

Statistics

Views

Abstract - 1224

PDF (Russian) - 483

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2013 Tipikina M.Y., Korniyenko Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies